• SPX
  • $5,969.34
  • 0.35 %
  • $20.63
  • DJI
  • $44,296.51
  • 0.97 %
  • $426.16
  • N225
  • $38,283.85
  • 0.68 %
  • $257.68
  • FTSE
  • $8,262.08
  • 1.38 %
  • $112.81
  • IXIC
  • $19,003.65
  • 0.16 %
  • $31.23
AgeX Therapeutics, Inc. (AGE) Stock Price, News & Analysis

AgeX Therapeutics, Inc. (AGE) Stock Price, News & Analysis

Currency in USD Disclaimer

NA

NA

NA

Day's range
$11.1
Day's range
$12.59
50-day range
$11.1
Day's range
$22.83
  • Country: US
  • ISIN: US00848H1086
52 wk range
$10.9
Day's range
$35.17
Notice: This company has been marked as potentially delisted and may not be actively trading.


We are preparing, please wait

Analyst Ratings

Key Stats

Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.

Stock Score/grades

The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company

  • Altman Z Score -3.24
  • Piotroski Score 4.00
  • Grade N/A
  • Symbol (AGE)
  • Company AgeX Therapeutics, Inc.
  • Price $11.10
  • Changes Percentage (-11.9%)
  • Change -$1.5
  • Day Low $11.10
  • Day High $12.59
  • Year High $35.17

AgeX Therapeutics, Inc., a biotechnology company, focuses on the development and commercialization of novel therapeutics targeting human aging and degenerative diseases in the United States. The company's lead cell-based therapeutic candidates in development include AGEX-BAT1, a cell therapy product candidate for the treatment of various age-related metabolic disorders, such as Type II adult-onset diabetes and obesity; and AGEX-VASC1, a cell-based therapy to restore vascular support in aged ischemic tissues, such as peripheral vascular disease and ischemic heart disease. Its lead drug-based therapeutic candidate for scarless wound repair in discovery is AGEX-iTR1547, a drug-based formulation; and lead biologic candidate for induced tissue regeneration is AGEX-iTR1550, a gene delivery technology. The company has a research collaboration with the University of California at Irvine to develop cellular therapies to treat neurological disorders and diseases. AgeX Therapeutics, Inc. was incorporated in 2017 and is based in Alameda, California.

  • Last Earnings
  • Ex-Dividend for 5/16 Dividend
  • Dividend Payable
  • Today N/A
  • Next Earnings (Estimated) 03/21/2024
  • Fiscal Year End N/A

  • Average Stock Price Target $0.00
  • High Stock Price Target $0.00
  • Low Stock Price Target $0.00
  • Potential Upside/Downside N/A
  • Consensus Rating Neutral
  • Rating Score (0-4) N/A
  • Research Coverage N/A

  • EPS (Most Recent Fiscal Year) -$482.53
  • Trailing P/E Ratio -0.02300375106211
  • Forward P/E Ratio -0.02300375106211
  • P/E Growth -0.02300375106211
  • Net Income $-14,803,000

Income Statement

Quarterly

Annual

Latest News of AGE

The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.

Enter your phone number to get Breaking News Updates

Stay ahead with instant updates! Enter your phone number for breaking news alerts, ensuring you're always in the know with the latest developments.


We are preparing, please wait

AgeX Therapeutics, Inc. Frequently Asked Questions

  • What is the AgeX Therapeutics, Inc. stock price today?

    Today's price of AgeX Therapeutics, Inc. is $11.10 — it has decreased by -11.9% in the past 24 hours. Watch AgeX Therapeutics, Inc. stock price performance more closely on the chart.

  • Does AgeX Therapeutics, Inc. release reports?

    Yes, you can track AgeX Therapeutics, Inc.'s financials in yearly and quarterly reports directly on Stocks.News.

  • What is the AgeX Therapeutics, Inc. stock forecast?

    Watch the AgeX Therapeutics, Inc. chart and read a more detailed AgeX Therapeutics, Inc. stock forecast to see what analysts suggest you do with its shares.

  • What is AgeX Therapeutics, Inc. stock ticker?

    The stock ticker can vary on the respective exchange. For instance, on AMEX, exchange stock trades by AgeX Therapeutics, Inc. stock ticker.

  • How to buy AgeX Therapeutics, Inc. stocks?

    Like other stocks, AGE shares are sold on stock exchanges such as AMEX. The best way to obtain them is through an online stock broker. Open an account, follow the broker's steps, and start trading.

  • What is AgeX Therapeutics, Inc.'s EBITDA?

    AgeX Therapeutics, Inc. measures a company's operating performance, and its growth indicates efficiency improvements. Access more stats in AgeX Therapeutics, Inc.’s financial statements.

  • What is the AgeX Therapeutics, Inc.'s net income ratio for the financial year 2023?

    The net income ratio for the financial year 2023 is -104.2464788732, which equates to approximately -10,424.65%. This ratio indicates the percentage of net income generated from total revenue and serves as a key measure of a company’s profitability.

  • Should I invest in AgeX Therapeutics, Inc. stocks?

    Investing in stocks requires thorough research. Carefully examine all available data, including AgeX Therapeutics, Inc.'s financials relevant news, and technical analysis. AgeX Therapeutics, Inc.'s technical analysis shows a “buy” rating today and a one-week “buy” rating. Since market conditions can change, it’s wise to look at longer-term trends — the one-month rating for AgeX Therapeutics, Inc. stock currently indicates a “sell” signal. For more insights, review AgeX Therapeutics, Inc.’s technical analysis.

  • A revenue figure for AgeX Therapeutics, Inc. for its last quarter?

    AgeX Therapeutics, Inc. published it's last quarterly revenues at $5,000.

Portfolio Sync Solutions

Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced

GET STARTED
Portfolio Sync Solutions
×
New Alert

Select an alert type

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.

New Alert

Setup alert

×

Premium Content

This content is only available for premium members. Please become a paid member to access.

Download App

Currently, memberships can only be purchased through the app.

×

Log In


or

download app using google store Continue with Google download app using apple Continue with Apple

Email Verification

An email with a verification code has been sent to your email address.

Welcome to Stocks.News!

Create Your Account

Email Verification

An email with a verification code has been sent to your email address.